
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Kansas City, Mo. - Tacrolimus 0.1 percent ointment suppresses signs and symptoms of allergic contact dermatitis among those sensitive to nickel and who continue to be exposed to the metal, according to researchers from the University of Missouri in Kansas City.